Q2 2019 Oncternal Therapeutics Inc Earnings Call Transcript
Greetings, and welcome to Oncternal Therapeutics Q2 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Richard Vincent, Chief Financial Officer. Please go ahead.
Thank you, operator. Good afternoon, everyone. I'd like to welcome you to our conference call to discuss Oncternal's second quarter financial results and provide an update of our clinical and preclinical development programs.
Earlier today, we issued our earnings release reporting financial results and business updates and plan to file our Form 10-Q for the quarter ended June 30, 2019 with the Securities and Exchange Commission tomorrow. Our filings and a replay of this call will be available on the Investors section of our website at www.oncternal.com for at least the next 30 days.
With me today is Oncternal's President and CEO, Dr. James
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |